Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory A Otterson

Showing results (51-60 of 157) with videos related to

Pageof 16
Sort By:
Clinical Lung Cancer|January 8, 2021
Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele FrequencyJean G Bustamante Alvarez, Sarah Janse, Dwight H Owen, et al.
Plos One|February 25, 2012
A novel classification of lung cancer into molecular subtypesLisandra West, Smruti J Vidwans, Nicholas P Campbell, et al.
Plos Medicine|March 29, 2007
Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancerRomulo M Brena, Carl Morrison, Sandya Liyanarachchi, et al.
Plos One|May 15, 2009
Expression of a mutant p53 results in an age-related demographic shift in spontaneous lung tumor formation in transgenic miceWenrui Duan, Li Gao, Xin Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
Pharmacobiologically based scheduling of capecitabine and docetaxel results in antitumor activity in resistant human malignanciesPadma Nadella, Charles Shapiro, Gregory A Otterson, et al.
Molecular and Cellular Biology|May 30, 2003
Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoterWei-Guo Zhu, Kanur Srinivasan, Zunyan Dai, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 2006
Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancerLaura T Smith, Mauting Lin, Romulo M Brena, et al.
The Oncologist|August 27, 2015
Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung CancerBalazs Halmos, Nathan A Pennell, Pingfu Fu, et al.
Oncogene|November 7, 2002
Lung-specific expression of human mutant p53-273H is associated with a high frequency of lung adenocarcinoma in transgenic miceWenrui Duan, Haiming Ding, Mark A Subler, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Homologous recombination and DNA repair mutations in patients treated with carboplatin and nab-paclitaxel for metastatic non-small cell lung cancerDwight H Owen, Terence M Williams, Erin M Bertino, et al.
Pageof 16

Showing results (51-60 of 157) with videos related to

Sort By:
Pageof 16
Clinical Lung Cancer|January 8, 2021
Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele FrequencyJean G Bustamante Alvarez, Sarah Janse, Dwight H Owen, et al.
Plos One|February 25, 2012
A novel classification of lung cancer into molecular subtypesLisandra West, Smruti J Vidwans, Nicholas P Campbell, et al.
Plos Medicine|March 29, 2007
Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancerRomulo M Brena, Carl Morrison, Sandya Liyanarachchi, et al.
Plos One|May 15, 2009
Expression of a mutant p53 results in an age-related demographic shift in spontaneous lung tumor formation in transgenic miceWenrui Duan, Li Gao, Xin Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
Pharmacobiologically based scheduling of capecitabine and docetaxel results in antitumor activity in resistant human malignanciesPadma Nadella, Charles Shapiro, Gregory A Otterson, et al.
Molecular and Cellular Biology|May 30, 2003
Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoterWei-Guo Zhu, Kanur Srinivasan, Zunyan Dai, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 2006
Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancerLaura T Smith, Mauting Lin, Romulo M Brena, et al.
The Oncologist|August 27, 2015
Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung CancerBalazs Halmos, Nathan A Pennell, Pingfu Fu, et al.
Oncogene|November 7, 2002
Lung-specific expression of human mutant p53-273H is associated with a high frequency of lung adenocarcinoma in transgenic miceWenrui Duan, Haiming Ding, Mark A Subler, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Homologous recombination and DNA repair mutations in patients treated with carboplatin and nab-paclitaxel for metastatic non-small cell lung cancerDwight H Owen, Terence M Williams, Erin M Bertino, et al.
Pageof 16